medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Title: Changes in COVID-19-related outcomes and the impacts of the potential risk factors over
time: a follow-up analysis

Authors: Youfei Yu1, MS; Tian Gu1, MS; Thomas S. Valley2,3, MD, MSc; Lars G. Fritsche1,4,5,
PhD; Bhramar Mukherjee1,4,5,6, PhD

Affiliations:
1

Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor

2

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine,

University of Michigan Medical School, Ann Arbor
3

Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor

4

Rogel Cancer Center, University of Michigan Medicine, Ann Arbor

5

Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor

6

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor

Corresponding Author: Bhramar Mukherjee, PhD, Department of Biostatistics, University of
Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, MI 48109
(bhramar@umich.edu).

Word Count: 2,397

1

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Key Points
Questions: How did the overall hospitalization and intensive care unit (ICU) admission rates
change over the course of the pandemic and how did they vary by race?
Findings: In this cohort study of 2,582 patients testing positive for COVID-19, the unadjusted
hospitalization rate decreased from 50.5% in Q1 (March 10, 2020, to March 31, 2020) to 17.9%
in Q3 (July 1, 2020, to September 2, 2020) for Black patients, and from 23.2% in Q1 to 13.8% in
Q3 for White patients. After adjusting for age, sex, sociodemographic factors, and comorbidity
conditions, the odds ratios of hospitalization between White and Black patients were not
significant in each quarter of the year 2020. No significant associations between ICU admission
and race/ethnic groups were identified in each quarter or the entire three quarters.
Meaning: These findings suggests an appreciable decline in hospitalization and ICU admission
rates among COVID-19 positive patients. The hospitalization and ICU admission rates across
race/ethnic groups became closer over time.

2

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Abstract
Importance: Characteristics of COVID-19 patients changed over the course of the pandemic.
Understanding how risk factors changed over time can enhance the coordination of healthcare
resources and protect the vulnerable.
Objective: To investigate the overall trend of severe COVID-19-related outcomes over time
since the start of the pandemic, and to evaluate whether the impacts of potential risk factors, such
as race/ethnic groups, changed over time.
Design: This retrospective cohort study included patients tested or treated for COVID-19 at
Michigan Medicine (MM) from March 10, 2020, to September 2, 2020. According to the quarter
in which they first tested positive, the COVID-19-positive cohort were stratified into three
groups: Q1, March 1, 2020 ‚Äì March 31, 2020; Q2, April 1, 2020 ‚Äì June 30, 2020; Q3, July 1,
2020 ‚Äì September 2, 2020.
Settings: Large, academic medical center.
Participants: Individuals tested or treated for COVID-19.
Exposure: Examined potential risk factors included age, race/ethnicity, smoking status, alcohol
consumption, comorbidities, body mass index (BMI), and residential-level socioeconomic
characteristics.
Main Outcomes and Measures: The main outcomes included COVID-19-related
hospitalization, intensive care unit (ICU) admission, and mortality, which were identified from
the electronic health records from MM.
Results: The study cohort consisted of 53,853 patients tested or treated for COVID-19 at MM,
with mean (SD) age of 44.8 (23.1), mean (SD) BMI of 29.1 (7.6), and 23,814 (44.2%) males.
Among the 2,582 patients who tested positive, 719 (27.8%) were hospitalized, 377 (14.6%) were

3

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

admitted to ICU, and 129 (5.0%) died. The overall COVID-positive hospitalization rate
decreased from 41.5% in Q1 to 12.6% in Q3, and the overall ICU admission rate decreased from
24.5% to 5.3%. Black patients had significantly higher (unadjusted) overall hospitalization rate
(265 [41.1%] vs 326 [23.2%]), ICU admission rate (139 [21.6%] vs 172 [12.2%]), and mortality
rate (42 [6.5%] vs 56 [4.0%]) than White patients. Each quarter, the hospitalization rate remained
higher for Black patients compared to White patients, but this difference was attenuated over
time for the (unadjusted) odds ratios (Q1: OR=1.9, 95% CI [1.25, 2.90]; Q2: OR=1.42, 95% CI
[1.02, 1.98]; Q3: OR=1.36, 95% CI [0.67, 2.65]). Similar decreasing patterns were observed for
ICU admission and mortality. Adjusting for age, sex, socioeconomic status, and comorbidity
score, the racial disparities in hospitalization between White and Black patients were not
significant in each quarter of the year (Q1: OR=1.43, 95% CI [0.75, 2.71]; Q2: OR=1.25, 95%
CI [0.79, 1.98]; Q3: OR=1.76 95% CI [0.81, 3.85]), in contrast to what was observed in the full
cohort (OR=1.85, 95% CI [1.39, 2.47]). Additionally, significant association of hospitalization
with living in densely populated area was identified in the first quarter (OR= 664, 95% CI [20.4,
21600]), but such association disappeared in the second and third quarters (Q2: OR= 1.72 95%
CI [0.22, 13.5]; Q3: OR=3.69, 95% CI [0.103, 132]). Underlying liver diseases were positively
associated with hospitalization in White patients (OR=1.60, 95% CI [1.01, 2.55], P=.046), but
not in Black patients (OR=0.49, 95% CI [0.23, 1.06], P=.072, Pint=.013). Similar results were
obtained for the effect of liver diseases on ICU admission in White and Black patients (White:
OR=1.75, 95% CI [1.01, 3.05], P=.047; Black: OR=0.46, 95% CI [0.17, 1.26], P=.130, Pint=.030).

Conclusions and Relevance: These findings suggest that the COVID-19-related hospitalization,
ICU admission, and mortality rates were decreasing over the course of the pandemic. Although

4

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

racial disparities persisted, the magnitude of the differences in hospitalization and ICU admission
rates diminished over time.

5

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Introduction
Since the World Health Organization declared coronavirus disease 2019 (COVID-19) a
pandemic on March 11, 2020,1 there have been over 77.1 million confirmed cases worldwide,
including 1.70 million deaths in the following eight months.2 The United States has surpassed 10
million cases, with the state of Michigan topping 496,000 confirmed cases and over 12,000
deaths as of December 21, 2020.3 Studies find that racial and ethnic minority groups were
disproportionately affected by COVID-19.4‚Äì13 For example, higher incidence of confirmed
cases,5,6,8,12 increased risk of hospitalization6,7,9,13 and greater fatality burden5,8,10,11 were
identified for Black individuals when compared to White individuals. Besides known racial
health disparities that impact the severity of COVID-19 outcomes, our previous study found risk
factors, such as cumulative comorbidity burden, to affect outcomes in White and Black patients
differently.9

Emerging evidence shows an appreciable decline in mortality rate among patients with severe
COVID-19 outcomes after the initial wave in March and April.14‚Äì16 A recent study conducted in
a single health system in New York City found that the hospital mortality rate dropped from 25.6%
at the start of the pandemic in March to 7.6% by mid-August 2020, adjusting for demographic
and clinical factors.15 The same trend of improved survival over time was seen among COVID19 patients requiring hospitalization16 or critical care management14 in England. Racial and
ethnic disparities still remain, but recent data showed reduced differences in age-adjusted case
fatality rate across ethnic groups.17 However, the dynamics of influencing risk factors on the
change of COVID-19 outcomes over time remain widely unknown. Understanding how risk

6

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

factors changed over the course of the pandemic can enhance the coordination of healthcare
resources and protect the vulnerable.

As an follow-up of the work of Gu et al.,9 this study aims to examine the sociodemographic and
clinical characteristics that are associated with various COVID-19 outcomes by race/ethnicity in
an expanded COVID-19 cohort, as well as to characterize the risk factor trajectory over time,
using electronic health records (EHRs) from Michigan Medicine (MM), a large academic health
care system in the State of Michigan.

Methods
Study Cohort and COVID-19 Testing
The study sample consisted of 53,853 patients tested or treated for COVID-19 at MM, the
University of Michigan Health System, from March 10, 2020, to September 2, 2020, with 2,582
testing positive. The sample was not randomly selected, as MM prioritized testing to those with
COVID symptoms or at greatest risk of exposure, particularly during the early stages of the
pandemic. Patients in the tested cohort received one of the four types of diagnostic tests: an inhouse polymerase chain reaction (PCR) test (51,781 patients [96.2%]), a commercial antibody
test (Viracor; 446 patients [.83%]), COVID-19 nasopharynx or oropharynx PCR tests deployed
by the Michigan Department of Health and Human Services (54 patients [.10%]), reverse
transcription‚ÄìPCR tests performed in external labs (975 patients [1.8%]), and a small fraction of
RNA test (4 patients [.007%]); 727 tested patients (1.3%) were transferred, tested elsewhere, or
had no information on the type of testing they received.

7

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

COVID-19 Outcomes
In this study, we focused on three different COVID-19-related outcomes among individuals who
have tested positive: hospitalization, intensive unit care (ICU) admission, and mortality, which
roughly represent various stages of disease progression. We also investigated the factors
associated with being tested and testing positive for COVID-19 using a randomly selected
untested comparison group (eMethod in the Supplement). The corresponding results are reported
in the Supplement. The definitions of these COVID-19 outcomes are listed in eTable 1, and the
sample sizes for each outcome are presented in eFigure 1 in the Supplement.

Definition of Demographics, Socioeconomic Status, Comorbidities, and Other Adjusted
Covariates
We followed the same process described in Gu et al.9 to extract the relevant variables from the
EHRs. The socio-demographic variables considered included age, self-reported sex,
race/ethnicity, smoking status, alcohol consumption, body mass index (BMI), neighborhood
socioeconomic disadvantage index (NDI),18 and population density (in persons per square
mile).18 To characterize the underlying medical conditions of the patients, we considered seven
comorbid conditions: respiratory conditions, circulatory conditions, any cancer, type 2 diabetes,
kidney diseases, and autoimmune diseases, all of which were coded binary. The general health
status of patients was represented by a comorbidity score ranging from 0 to 7 that sums up the
aforementioned seven conditions. In addition, those who had at least one encounter in any of the
primary care locations in MM since January 1, 2018, were regarded as seeking primary care.

8

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Statistical Analysis
For each COVID-related outcome ‡≠á‡≠ì‡≠ö‡≠ç‡≠à , we fit a Firth‚Äôs bias-corrected logistic regression to
avoid the potential separation issues in the traditional maximum likelihood estimates. The
analysis model is given by

logit 

‡≠á‡≠ì‡≠ö‡≠ç‡≠à

1|, 

‡¨¥  ‡Øë   ‡Æº‡Ø¢‡Ø© , # 1

where  and e denote the risk factor of interest and the vector of covariates,
respectively. We explored four nested sets of variables for e, respectively labeled
adjustment 0-3 (defined in eTable 1 in the Supplement), to check the robustness of inference to
the choice of potential confounders (eTable 2 in the Supplement). Our final model (adjustment 3)
adjusted for age, sex, race/ethnicity, population density, NDI, and comorbidity score. We
excluded the accumulative comorbidity score when the factor of interest  was one of the
individual comorbid conditions. The models for being tested and testing positive further adjusted
for population density.

We further conducted a quarter-stratified analysis to assess the changes in racial disparities and
the effects of other risk factors for severe COVID-19-related outcomes over time since the start
of the pandemic. The  variable was self-reported and defined as four categories: White,
Black, other known race/ethnicity, and unknown race/ethnicity. According to the quarter in
which they first tested positive, the COVID-19-positive cohort were stratified into three groups:
Q1, March 1, 2020 ‚Äì March 31, 2020; Q2, April 1, 2020 ‚Äì June 30, 2020; Q3, July 1, 2020 ‚Äì
September 2, 2020. Similarly, the COVID-19-negative cohort were stratified by the quarter in

9

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

which they first received the tests. The logistic regression model 1 was fitted using data for
each quarter.

To evaluate the effect of race/ethnicity on the potential risk factors, we fit a set of models with
interactions by race:

logit 

‡≠á‡≠ì‡≠ö‡≠ç‡≠à

1|, , 
‡¨¥  ‡Øë   ‡Øã‡Øî‡Øñ‡Øò   ‡Øú‡Ø°‡Øß     ‡Æº‡Ø¢‡Ø© .

For each model, we report the Firth‚Äôs bias-corrected estimates of odds ratios along with their
associated 95% Wald confidence intervals (CI) and P-values. For the interaction models, we also
obtained the P-values of the differences in subgroup effects for White and Black patients by
testing the null hypothesis ‡Øú‡Ø°‡Øß

0. All analyses were performed using complete cases in R

statistical software version 3.6.2 (R Project for Statistical Computing).

Results

Descriptive Statistics
Table 1 summarizes the descriptive statistics for the tested cohort and each of the subgroups.
The tested cohort included 53,853 patients, with mean (SD) age of 44.8 (23.1), mean (SD) BMI
of 29.1 (7.6), and 23,814 (44.2%) males. During the study period, more White patients
(n=38,977 [72.4%]) were tested than the other races/ethnicities, with 1,492 (66.1%), 17,213
(73.5%), and 19,911 (72.2%) White patients tested in Q1, Q2, and Q3, respectively. The
proportions of patients of age"65 increased over time among those who have been tested

10

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

(eTables 3A-3C). The untested comparison group consisted of 29,383 individuals, with mean
(SD) age of 43.2 (24.4), mean (SD) BMI of 28.5 (7.3), and 13,581 (46.3%) males.

Among the 2,582 patients who have tested positive, 719 (27.8%) were hospitalized, 377 (14.6%)
were admitted to ICU, and 129 (5.0%) died. Older patients, male sex, ever smokers, and
increased comorbidity burden tended to be associated with worsened disease severity among
COVID-19-positive patients. From Q1 to Q3, the mean and median age in general decreased
over time for patients who were hospitalized or admitted to ICU. We observed a greater
percentage of Black than White patients among those who were hospitalized or admitted to ICU
patients in Q1. However, this relationship reversed in Q2 and Q3.

Stratifying the descriptive statistics by White and Black patients, we noted differences in
covariate distributions between the two groups (eTable 4). For example, in the tested cohort,
Black patients tended to be younger (mean [SD] age, 42.8 [21.7] vs 46.1 [23.3]), live in higher
populated area (mean [SD] population density in persons per square mile, 3590 [2410] vs 2110
[2260]), have greater socioeconomic disadvantage (mean [SD] NDI, 0.18 [0.10] vs 0.09 [0.06]),
and have higher burden of underlying medical conditions (mean [SD] comorbidity score, 2.53
[1.61] vs 2.29 [1.53]) than White patients. Similar pattern existed in the subgroups (e.g.,
hospitalized patients) of the tested cohort. The fractions of missingness for each characteristic are
presented in eTable 5.

Figure 1 indicated the changes in the overall and race-stratified COVID-19 outcomes over time.
The overall hospitalization rate among patients testing positive decreased from 41.5% in Q1 to

11

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

12.6% in Q3, and the overall ICU admission rate decreased from 24.5% to 5.3%. In the full
cohort, Black patients had significantly higher (unadjusted) hospitalization rate (265 [41.1%] vs
326 [23.2%]), ICU admission rate (139 [21.6%] vs 172 [12.2%]), and mortality rate (42 [6.5%]
vs 56 [4.0%]) than White patients. When we examined each quarter, the hospitalization rate
remained higher for Black patients compared to White patients, but this difference was
attenuated over time for the (unadjusted) odds ratios (Q1: OR=1.9, 95% CI [1.25, 2.90]; Q2:
OR=1.42, 95% CI [1.02, 1.98]; Q3: OR=1.36, 95% CI [0.67, 2.65]). Similar decreasing pattern
was observed for ICU admission and mortality. In particular, Black patients had lower ICU
admission rate in Q3 (4 [5.1%] vs 26 [5.8%]) and lower mortality rate in Q2 (15 [6.3%] vs 37
[9.2%]) and Q3 (0 [0%] vs 1 [0.2%]), though the differences were not statistically significant due
to the small number of patients. At the end of the analysis, 22 patients were still hospitalized
(n=5) or still in ICU (n=17).

Factors Associated with COVID-19 Testing
Overall, male sex, higher BMI, ever smoker, alcohol consumption, Black patients, lower NDI,
areas with higher population densities, accumulation of comorbidities were associated with an
increased chance of getting tested. These associations were fairly consistent over quarters
(eTable 6).

Factors Associated with COVID-19-Related Outcomes Among COVID-19-Positive Patients
Among the patients who tested positive for COVID-19 through September 2, 2020, Black
patients had significantly higher (covariate adjusted) odds of being hospitalized compared to
White patients (OR=1.85, 95% CI [1.39, 2.47]). The differences in ICU admission (OR=1.33, 95%

12

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

CI [0.93, 1.90]) and mortality (OR=1.46, 95% CI [0.81, 2.64]) were not significant after
covariate adjustment (Figure 1). Every 10-year increase in age, male sex, living in densely
populated areas or disadvantaged neighborhoods, and heavier overall comorbidity burden were
positively associated with hospitalization, ICU admission, and mortality (Table 2).

The racial disparities in hospitalization were not significant in each quarter of the year (Q1:
OR=1.43, 95% CI [0.75, 2.71]; Q2: OR=1.25, 95% CI [0.79, 1.98]; Q3: OR=1.76 95% CI [0.81,
3.85]), in contrast to what was observed in the full cohort (eTable 6), possibly due to the reduced
sample size after stratification. Additionally, significant association of hospitalization with living
in densely populated areas was identified in the first quarter (OR= 664, 95% CI [20.4, 21600]),
but such association disappeared in the second and third quarters (Q2: OR= 1.72 95% CI [0.22,
13.5]; Q3: OR=3.69, 95% CI [0.103, 132]). Similar pattern was observed for ICU admission
(eTable 6).

Underlying liver diseases were positively associated with hospitalization in White patients
(OR=1.60, 95% CI [1.01, 2.55], P=.046), but not in Black patients (OR=0.49, 95% CI [0.23,
1.06], P=.072, Pint=.013) (Figure 2A). Similar results were obtained for the effect of liver
diseases on ICU admission in White and Black patients (White: OR=1.75, 95% CI [1.01, 3.05],
P=.047; Black: OR=0.46, 95% CI [0.17, 1.26], P=.130, Pint=.030) (Figure 2B). Consistent with
Gu et al.,9 the comorbidity score was a significant risk factor for hospitalization in White patients
(OR=1.29, 95% CI [1.16, 1.44], P<0.001), but not in Black patients (OR=1.12, 95% CI [0.98,
1.29], P=0.098), though the interaction was not significant (Pint=.15).

13

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Discussion

In this study, we evaluated the potential risk factors for COVID-19 prognosis using a larger
cohort from the same healthcare system that covered a longer time frame than Gu et al.9 We
observed that patients in racial minority group and with higher comorbidity burden were more
susceptible to COVID-19 and more likely to be hospitalized, a result consistent with previous
studies in the literature. On the other hand, the association between every 10-year increase in age
and positive test results reversed compared to what was reported in Gu et al.,9 such that younger
people, especially those aged 18-35 years, were more likely to be tested positive. The finding
aligns with the recent data from Centers for Disease Control and Prevention, which shows an
increase in the COVID-19 incidence in persons aged <30 years and a decrease in the median age
for confirmed cases during May-August 2020.19

We observed a decline in the overall hospitalization and ICU admission rates over time, which
may be partly explained by the rapid increase in testing from Q1 to Q3. The analysis stratified by
quarters suggests less obvious contrast in COVID-19 outcomes between Black and White
patients over time. Additionally, there was a reduction in socioeconomic disparity with regard to
severe COVID-19 outcomes, as the socioeconomic variables NDI and population density were in
general not significantly associated with hospitalization and ICU-admission in the second and the
third quarter.

A large fraction (n=169 [23.5%]) of patients who were hospitalized in our sample was
transferred from external hospitals, mainly from the Detroit Metro area. These transferred

14

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

patients tended to have more severe symptoms and different distributions in sociodemographic
characteristics from non-transferred patients. It is important to note the temporal changes in the
context of care at MM (eTable 7). There was an enrichment in transferred patients in Q2 (n=93
[25.6%]) compared to Q1 (n=30 [15.0%]) and Q3 (n=11 [12.8%]) for those hospitalized.
However, a sensitivity analysis that excluded patients who do not receive their primary care at
Michigan Medicine was consistent with the overall analysis, namely improved outcomes and
reduced health disparities over time (eFigure 8).

Our findings suggest that the COVID-19-related hospitalization, ICU admission, and mortality
rates were decreasing over the course of the pandemic. Although racial disparities persisted, the
magnitude of the differences in hospitalization and ICU admission rates diminished over time.
This study also identifies a number of potential risk factors for COVID-19-related outcomes:
older adults, male sex, racial minority groups, those with preexisting conditions, and those with
poorer socioeconomic status. Our results can be useful for vaccine prioritization after the
vaccines for COVID-19 becomes available.

15

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

References
1.

Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Bio Med.
2020;91(1):157-160. doi:10.23750/abm.v91i1.9397

2.

COVID-19 Map. Johns Hopkins Coronavirus Resource Center. Accessed December 21,
2020. https://coronavirus.jhu.edu/map.html

3.

Coronavirus - Michigan Data. Accessed December 21, 2020.
https://www.michigan.gov/coronavirus/0,9753,7-406-98163_98173---,00.html

4.

Webb Hooper M, N√°poles AM, P√©rez-Stable EJ. COVID-19 and Racial/Ethnic Disparities.
JAMA. 2020;323(24):2466. doi:10.1001/jama.2020.8598

5.

Millett GA, Jones AT, Benkeser D, et al. Assessing differential impacts of COVID-19 on
black communities. Annals of Epidemiology. 2020;47:37-44.
doi:10.1016/j.annepidem.2020.05.003

6.

Mu√±oz-Price LS, Nattinger AB, Rivera F, et al. Racial Disparities in Incidence and
Outcomes Among Patients With COVID-19. JAMA Netw Open. 2020;3(9):e2021892.
doi:10.1001/jamanetworkopen.2020.21892

7.

Azar KMJ, Shen Z, Romanelli RJ, et al. Disparities In Outcomes Among COVID-19
Patients In A Large Health Care System In California. Health Affairs. 2020;39(7):12531262. doi:10.1377/hlthaff.2020.00598

8.

Tirupathi R, Muradova V, Shekhar R, Salim SA, Al-Tawfiq JA, Palabindala V. COVID-19
disparity among racial and ethnic minorities in the US: A cross sectional analysis. Travel
Medicine and Infectious Disease. 2020;38:101904. doi:10.1016/j.tmaid.2020.101904

9.

Gu T, Mack JA, Salvatore M, et al. Characteristics Associated With Racial/Ethnic
Disparities in COVID-19 Outcomes in an Academic Health Care System. JAMA Netw
Open. 2020;3(10):e2025197. doi:10.1001/jamanetworkopen.2020.25197

10. Ojinnaka CO, Adepoju OE, Burgess AV, Woodard L. Factors Associated with COVIDRelated Mortality: the Case of Texas. J Racial and Ethnic Health Disparities. Published
online November 9, 2020. doi:10.1007/s40615-020-00913-5
11. Alcendor DJ. Racial Disparities-Associated COVID-19 Mortality among Minority
Populations in the US. Journal of Clinical Medicine. 2020;9(8):2442.
doi:10.3390/jcm9082442
12. Moore JT. Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic
Groups in Counties Identified as Hotspots During June 5‚Äì18, 2020 ‚Äî 22 States, February‚Äì
June 2020. MMWR Morb Mortal Wkly Rep. 2020;69. doi:10.15585/mmwr.mm6933e1
13. Gianfrancesco MA, Leykina LA, Izadi Z, et al. Race/ethnicity association with COVID-19
outcomes in rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance
16

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Physician Registry. Arthritis Rheumatol. Published online November 3, 2020.
doi:10.1002/art.41567
14. Dennis JM, McGovern AP, Vollmer SJ, Mateen BA. Improving Survival of Critical Care
Patients With Coronavirus Disease 2019 in England: A National Cohort Study, March to
June 2020. Critical Care Medicine. 2020;Online First.
doi:10.1097/CCM.0000000000004747
15. Horwitz LI, Jones SA, Cerfolio RJ, et al. Trends in COVID-19 Risk-Adjusted Mortality
Rates. J Hosp Med. 2020;(2020-10-23 ONLINE FIRST). doi:10.12788/jhm.3552
16. Griffin S. Covid-19: Continued outbreaks in care homes risk extending pandemic, say
experts. BMJ. 2020;369. doi:10.1136/bmj.m2530
17. Fabic MS, Choi Y, Bishai D. Deaths among COVID Cases in the United States: Racial and
Ethnic Disparities Persist. medRxiv. Published online November 17,
2020:2020.11.15.20232066. doi:10.1101/2020.11.15.20232066
18. NaNDA | Social Environment and Health Program. Accessed November 12, 2020.
https://seh.isr.umich.edu/signature-projects/nanda/
19. Boehmer TK. Changing Age Distribution of the COVID-19 Pandemic ‚Äî United States,
May‚ÄìAugust 2020. MMWR Morb Mortal Wkly Rep. 2020;69.
doi:10.15585/mmwr.mm6939e1

17

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Table 1. Descriptive Characteristics of the COVID-19 Tested or Diagnosed Cohort
a
Individuals, no. (%)
Tested for COVID-19
Positive Results
Negative
Hospitali
Decease
Overall
Results
Overall
zed
ICU
d
(n =
(n =
Variable
53853)
51271)
(n = 2582) (n = 719)
(n = 377)
(n = 129)
Age, y
44.8
44.7
58.5
58.6
Mean (SD) (23.1)
(23.2)
47.4 (20)
(17.6)
(17.5)
69 (14.3)
Median (IQR) 47 (38)
46 (38)
49 (31)
61 (23)
61 (22)
71 (22)
6895
6768
<18 (12.8)
(13.2)
127 (4.9)
14 (1.9)
10 (2.7)
0 (0)
12652
12017
[18,35) (23.5)
(23.4)
635 (24.6) 65 (9)
33 (8.8)
3 (2.3)
9273
[35,50) (17.2)
8697 (17) 576 (22.3) 125 (17.4) 56 (14.9)
11 (8.5)
12116
11440
[50,65) (22.5)
(22.3)
676 (26.2) 224 (31.2) 120 (31.8) 33 (25.6)
10257
9825
[65,80) (19)
(19.2)
432 (16.7) 209 (29.1) 124 (32.9) 43 (33.3)
>=80 2660 (4.9) 2524 (4.9) 136 (5.3)
82 (11.4)
34 (9)
39 (30.2)
23814
22651
Men
(44.2)
(44.2)
1163 (45) 403 (56.1) 233 (61.8) 80 (62)
Primary Care
31357
29969
1388
in MM
(58.2)
(58.5)
(53.8)
253 (35.2) 128 (34)
35 (27.1)
BMI
32.6
32.9
Mean (SD) 29.1 (7.6) 29.1 (7.6) 30.9 (8.4) (10.1)
(11.5)
31.3 (6.9)
<18.5 826 (1.9)
804 (2)
22 (1)
9 (1.3)
4 (1.1)
1 (0.8)
12857
12357
[18.5,25) (29.7)
(30)
500 (22.9) 102 (14.9) 61 (16.9)
17 (13.7)
13371
12723
[25,30) (30.8)
(30.9)
648 (29.7) 211 (30.9) 110 (30.5) 45 (36.3)
16291
15281
1010
>=30 (37.6)
(37.1)
(46.3)
361 (52.9) 186 (51.5) 61 (49.2)
Smoking
Status
31041
29549
1492
Never (63.2)
(63)
(68.7)
368 (60.2) 159 (54.6) 30 (39)
13725
13145
Past (28)
(28)
580 (26.7) 219 (35.8) 120 (41.2) 44 (57.1)
Current
Ever
Alcohol
consumption
Race/ethnicity
White
Black

Comparis
on Group
(n =
29383)
43.2
(24.4)
43 (42)
5345
(18.2)
6731
(22.9)
4593
(15.6)
5659
(19.3)
5128
(17.5)
1916 (6.5)
13581
(46.3)
4318
(14.7)

28.5 (7.3)
357 (2.2)
5278
(32.8)
5020
(31.2)
5455
(33.9)

4314 (8.8)
18039
(36.8)
25894
(68.4)

4215 (9)
17360
(37)
24768
(68.6)

99 (4.6)

24 (3.9)

12 (4.1)

3 (3.9)

679 (31.3)
1126
(66.2)

243 (39.8)

132 (45.4)

47 (61)

261 (63.2)

128 (63.7)

35 (61.4)

15002
(68.9)
4615
(21.2)
2168
(10.0)
6783
(31.1)
8542
(55.0)

38977
(72.4)
5763
(10.7)

37566
(73.3)

1411
(54.6)

326 (45.3)

172 (45.6)

56 (43.4)

18529
(63.1)

5117 (10)

646 (25)

265 (36.9)

139 (36.9)

42 (32.6)

2165 (7.4)

18

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Otherb

4869 (9)

4616 (9)

253 (9.8)

63 (8.8)

21 (5.6)

6 (4.7)

2731 (9.3)
5958
(20.3)

Unknownc 4244 (7.9) 3972 (7.7) 272 (10.5) 65 (9)
45 (11.9)
25 (19.4)
NDI, mean
0.19
(SD)
0.18 (0.1) 0.18 (0.1) (0.11)
0.2 (0.1)
0.21 (0.1) 0.21 (0.1) 0.19 (0.1)
Population
density,
persons/squar 2375.8
2343.2
2997.3
3658.7
3826.4
4128.4
2335.1
e mile
(2422.1)
(2412.8)
(2512.8)
(2635)
(2675.2)
(2770.3)
(2495.1)
Comorbidity
score,
mean (SD)
2.3 (1.5)
2.2 (1.5)
2.3 (1.5)
3.1 (1.6)
3.3 (1.6)
3.9 (1.5)
1.3 (1.2)
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters
squared); COVID-19, coronavirus disease 2019; ICU, intensive care unit; IQR, interquartile range; NDI,
2010 Neighborhood Socioeconomic Disadvantage Index; MM, Michigan Medicine.
a
Percentages are reported as fraction of column totals excluding missing entries.
b
Includes White Hispanic or unknown; Black Hispanic or unknown; Asian Hispanic,non-Hispanic, or
unknown; Native American Hispanic, non-Hispanic, or unknown;Pacific Islander Hispanic, non-Hispanic,
or unknown; and other Hispanic, non-Hispanic, or unknown.
c
Includes missing race and/or ethnicity
Table 1. Descriptive Characteristics of the COVID-19 Tested or Diagnosed Cohort
Individuals, no. (%)a
Tested for COVID-19
Positive Results
Negative
Hospitali
Decease
Comparis
Overall
Results
Overall
zed
ICU
d
on Group
(n =
(n =
(n =
Variable
53853)
51271)
(n = 2582) (n = 719)
(n = 377)
(n = 129)
29383)
Age, y
44.8
44.7
58.5
58.6
43.2
Mean (SD) (23.1)
(23.2)
47.4 (20)
(17.6)
(17.5)
69 (14.3)
(24.4)
Median (IQR) 47 (38)
46 (38)
49 (31)
61 (23)
61 (22)
71 (22)
43 (42)
6895
6768
5345
<18 (12.8)
(13.2)
127 (4.9)
14 (1.9)
10 (2.7)
0 (0)
(18.2)
12652
12017
6731
[18,35) (23.5)
(23.4)
635 (24.6) 65 (9)
33 (8.8)
3 (2.3)
(22.9)
9273
4593
[35,50) (17.2)
8697 (17) 576 (22.3) 125 (17.4) 56 (14.9)
11 (8.5)
(15.6)
12116
11440
5659
[50,65) (22.5)
(22.3)
676 (26.2) 224 (31.2) 120 (31.8) 33 (25.6)
(19.3)
10257
9825
5128
[65,80) (19)
(19.2)
432 (16.7) 209 (29.1) 124 (32.9) 43 (33.3)
(17.5)
>=80 2660 (4.9) 2524 (4.9) 136 (5.3)
82 (11.4)
34 (9)
39 (30.2)
1916 (6.5)
23814
22651
13581
Men
(44.2)
(44.2)
1163 (45) 403 (56.1) 233 (61.8) 80 (62)
(46.3)
Primary Care
31357
29969
1388
4318
in MM
(58.2)
(58.5)
(53.8)
253 (35.2) 128 (34)
35 (27.1)
(14.7)
BMI
32.6
32.9
Mean (SD) 29.1 (7.6) 29.1 (7.6) 30.9 (8.4) (10.1)
(11.5)
31.3 (6.9) 28.5 (7.3)
<18.5 826 (1.9)
804 (2)
22 (1)
9 (1.3)
4 (1.1)
1 (0.8)
357 (2.2)
12857
12357
5278
[18.5,25) (29.7)
(30)
500 (22.9) 102 (14.9) 61 (16.9)
17 (13.7)
(32.8)
[25,30) 13371
12723
648 (29.7) 211 (30.9) 110 (30.5) 45 (36.3)
5020

19

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

>=30

(30.8)
16291
(37.6)

(30.9)
15281
(37.1)

31041
(63.2)
13725
(28)

(31.2)
5455
(33.9)

1010
(46.3)

361 (52.9)

186 (51.5)

61 (49.2)

29549
(63)
13145
(28)

1492
(68.7)

368 (60.2)

159 (54.6)

30 (39)

580 (26.7)

219 (35.8)

120 (41.2)

44 (57.1)

4314 (8.8)
18039
(36.8)
25894
(68.4)

4215 (9)
17360
(37)
24768
(68.6)

99 (4.6)

24 (3.9)

12 (4.1)

3 (3.9)

679 (31.3)
1126
(66.2)

243 (39.8)

132 (45.4)

47 (61)

261 (63.2)

128 (63.7)

35 (61.4)

15002
(68.9)
4615
(21.2)
2168
(10.0)
6783
(31.1)
8542
(55.0)

38977
(72.4)
5763
(10.7)
4869 (9)

37566
(73.3)

1411
(54.6)

326 (45.3)

172 (45.6)

56 (43.4)

18529
(63.1)

5117 (10)
4616 (9)

646 (25)
253 (9.8)

265 (36.9)
63 (8.8)

139 (36.9)
21 (5.6)

42 (32.6)
6 (4.7)

Smoking
Status
Never
Past
Current
Ever
Alcohol
consumption
Race/ethnicity
White
Black
Otherb

2165 (7.4)
2731 (9.3)
5958
(20.3)

Unknownc 4244 (7.9) 3972 (7.7) 272 (10.5) 65 (9)
45 (11.9)
25 (19.4)
NDI, mean
0.19
(SD)
0.18 (0.1) 0.18 (0.1) (0.11)
0.2 (0.1)
0.21 (0.1) 0.21 (0.1) 0.19 (0.1)
Population
density,
persons/squar 2375.8
2343.2
2997.3
3658.7
3826.4
4128.4
2335.1
e mile
(2422.1)
(2412.8)
(2512.8)
(2635)
(2675.2)
(2770.3)
(2495.1)
Comorbidity
score,
mean (SD)
2.3 (1.5)
2.2 (1.5)
2.3 (1.5)
3.1 (1.6)
3.3 (1.6)
3.9 (1.5)
1.3 (1.2)
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters
squared); COVID-19, coronavirus disease 2019; ICU, intensive care unit; IQR, interquartile range; NDI,
2010 Neighborhood Socioeconomic Disadvantage Index; MM, Michigan Medicine.
a
Percentages are reported as fraction of column totals excluding missing entries.
b
Includes White Hispanic or unknown; Black Hispanic or unknown; Asian Hispanic,non-Hispanic, or
unknown; Native American Hispanic, non-Hispanic, or unknown;Pacific Islander Hispanic, non-Hispanic,
or unknown; and other Hispanic, non-Hispanic, or unknown.
c
Includes missing race and/or ethnicity

20

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

Table 2. Odds Ratios (95% Confidence Intervals) for COVID-19-Related Outcomes in the Full
Cohort
Variable
Hospitalized vs. not
ICU vs. not
Deceased vs. not
Sample size, No.
Comparative group
1852
2194
2453
COVID-19 outcome
719
377
129
group
Age, y
Per 10-year increase
1.46 (1.36, 1.56)
1.34 (1.23, 1.47)
2.10 (1.74, 2.52)
<18
1.24 (0.60, 2.56)
2.21 (0.91, 5.38)
1.09 (0.05, 22.1)
18 to <35
1 [Reference]
1 [Reference]
1 [Reference]
35 to <50
1.51 (1, 2.28)
1.42 (0.78, 2.58)
1.74 (0.41, 7.38)
50 to <65
2.62 (1.78, 3.85)
2.56 (1.48, 4.44)
2.95 (0.77, 11.3)
65 to <80
4.62 (3.07, 6.95)
4.39 (2.51, 7.70)
7.14 (1.91, 26.7)
>=80
13.3 (7.51, 23.4)
5.39 (2.67, 10.9)
36.5 (9.49, 140)
Male sex
1.84 (1.46, 2.31)
2.33 (1.74, 3.13)
1.93 (1.19, 3.13)
BMI
Per 1-unit increase
1.02 (1, 1.04)
1.01 (0.99, 1.03)
1.02 (0.99, 1.05)
<18.5
3.61 (1.17, 11.2)
2.96 (0.76, 11.6)
6.34 (0.65, 61.6)
18.5 to <25
1 [Reference]
1 [Reference]
1 [Reference]
25 to <30
1.47 (1.02, 2.14)
1.17 (0.73, 1.86)
1.54 (0.66, 3.62)
>=30
1.60 (1.12, 2.27)
1.08 (0.69, 1.68)
2.08 (0.91, 4.79)
Smoking Status
Ever
1.09 (0.85, 1.40)
1.29 (0.94, 1.77)
1.45 (0.82, 2.58)
Never
1 [Reference]
1 [Reference]
1 [Reference]
Past
1.15 (0.88, 1.49)
1.35 (0.97, 1.87)
1.50 (0.84, 2.68)
Current
0.78 (0.43, 1.43)
1.00 (0.46, 2.16)
1.09 (0.18, 6.46)
Alcohol consumption
0.77 (0.59, 1.01)
0.81 (0.57, 1.15)
1.05 (0.56, 1.95)
Race/ethnicity
White
1 [Reference]
1 [Reference]
1 [Reference]
Black
1.85 (1.39, 2.47)
1.33 (0.93, 1.90)
1.46 (0.81, 2.64)
Otherb
1.15 (0.75, 1.75)
0.82 (0.45, 1.48)
1.26 (0.48, 3.32)
Unknown
1.11 (0.69, 1.78)
1.43 (0.81, 2.52)
5.44 (2.63, 11.3)
NDI
11.7 (3.08, 44.4)
20.7 (4.17, 102)
110 (9.92, 1230)
Population density, per
1000 persons/square
1.07 (1.02, 1.13)
1.10 (1.03, 1.17)
1.11 (1.01, 1.23)
mile
Comorbidity
Comorbidity score
1.24 (1.15, 1.35)
1.34 (1.21, 1.48)
1.52 (1.29, 1.79)
Respiratory diseasesc
1.14 (0.86, 1.52)
1.36 (0.94, 1.97)
2.50 (1.22, 5.13)
c
Circulatory diseases
1.58 (1.16, 2.15)
1.62 (1.07, 2.45)
2.91 (1.09, 7.78)
Any cancerc
1.17 (0.90, 1.53)
1.32 (0.96, 1.83)
1.62 (0.99, 2.65)
Type 2 diabetesc
1.79 (1.39, 2.32)
1.89 (1.39, 2.59)
3.39 (2.07, 5.57)
c
Kidney diseases
3.20 (2.41, 4.24)
3.64 (2.64, 5.02)
3.82 (2.31, 6.31)
Liver diseasesc
1.24 (0.86, 1.80)
1.34 (0.86, 2.09)
1.67 (0.85, 3.26)
Autoimmune diseasesc
1.06 (0.80, 1.41)
1.30 (0.93, 1.84)
0.93 (0.52, 1.67)
Abbreviations: BMI, body mass index; ICU, intensive unit care; NDI, Neighborhood Socioeconomic
Disadvantage Index.
a
Results were obtained from Firth‚Äôs multivariable logistic regression model
|, 
  ‡°Ø‡°ª‡¢Ç‡°µ‡°∞
‡´ô  ‡¢Ñ   ‡°Ø‡¢ï‡¢ú , where ‡°Ø‡°ª‡¢Ç‡°µ‡°∞ is the COVID-19
outcomes (i.e. positive test results, hospitalization, admission to ICU, or mortality).  = age +
sex + race + NDI + comorbidity score (+ population density in models for positive test results).
b
Includes White Hispanic or unknown; Black Hispanic or unknown; Asian Hispanic, non-Hispanic, or
unknown; Native American Hispanic, non-Hispanic, or unknown; Pacific Islander Hispanic, non-Hispanic,

21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

or unknown; and other Hispanic, non-Hispanic,
or unknown.
c
Not adjusted for composite comorbidity score.

22

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Full Cohort

50

41.1%
(265/644)

40
28.0%
(719/2571)

30

23.2%
(326/1406)

21.6%
(139/644)
14.7%
(377/2571)

20

12.2%
(172/1406)
5.0%
(129/2582)

10

4.0%
(56/1411)

Q1

60

All Race/Ethnicity
White
Black

Percentage [%]

Percentage [%]

60

6.5%
(42/646)

All Race/Ethnicity
White
Black

50.5%
(104/206)

50

41.5%
(200/482)
34.8%
(69/198)

40

24.5%
(118/482)

30
20

7.2%
(35/483)

10

0

6.6%
(13/198)

10.1%
(21/207)

0

Unadjusted
Unadjusted

+

Hospitalization

ICU

Deceased

2.32 (1.89, 2.84)

1.97 (1.53, 2.54)

1.68 (1.09, 2.59)

2.32 (1.9, 2.83)

1.97 (1.54, 2.53)

1.69 (1.12, 2.54)

Adjustment 1

a,+

2.63 (2.11, 3.28)

2.1 (1.62, 2.73)

1.87 (1.21, 2.88)

Adjustment 2

b,+

2.1 (1.63, 2.7)

1.59 (1.18, 2.15)

1.43 (0.871, 2.36)

Adjustment 3

c,+

1.85 (1.39, 2.47)

1.33 (0.931, 1.9)

1.46 (0.813, 2.64)

Unadjusted
Unadjusted

+

Hospitalization

ICU

Deceased

1.9 (1.25, 2.9)

1.44 (0.9, 2.32)

1.6 (0.74, 3.6)

1.9 (1.27, 2.83)

1.43 (0.915, 2.25)

1.58 (0.777, 3.23)

Adjustment 1

a,+

2.39 (1.49, 3.84)

1.75 (1.04, 2.94)

2.12 (0.96, 4.68)

Adjustment 2

b,+

1.25 (0.711, 2.19)

1.05 (0.563, 1.95)

1.62 (0.599, 4.38)

Adjustment 3

c,+

1.43 (0.752, 2.71)

0.985 (0.471, 2.06)

1.72 (0.508, 5.81)

Q2
50

42.8%
(171/400)

40
24.2%
(198/817)

30

24.2%
(97/400)

27.2%
(65/239)

20
8.5%
(70/823)

10

9.2%
(37/403)

Q3

60

All Race/Ethnicity
White
Black

51.5%
(123/239)
44.4%
(363/817)

Percentage [%]

60
Percentage [%]

29.1%
(60/206)
22.2%
(44/198)

6.3%
(15/239)

All Race/Ethnicity
White
Black

50
40
30
20

12.6%
(86/683)

13.8%
(62/449)

17.9%
(14/78)
5.3%
(36/683)

10

5.8%
(26/449)

5.1%
(4/78)

0.6%
(4/683)

0.2%
(1/449)

0.0%
(0/78)

0

0
Hospitalization

ICU

Deceased

Unadjusted

1.42 (1.02, 1.98)

1.17 (0.79, 1.71)

0.66 (0.33, 1.27)

+

1.42 (1.03, 1.96)

1.17 (0.811, 1.68)

0.675 (0.365, 1.25)

Unadjusted
Adjustment 1

a,+

1.61 (1.15, 2.26)

1.25 (0.86, 1.81)

0.784 (0.412, 1.49)

Adjustment 2

b,+

1.53 (1.04, 2.25)

1.13 (0.737, 1.73)

0.746 (0.363, 1.54)

Adjustment 3

c,+

1.25 (0.79, 1.98)

0.941 (0.553, 1.6)

0.879 (0.374, 2.07)

Hospitalization

ICU

Deceased

Unadjusted

1.36 (0.67, 2.65)

0.88 (0.22, 2.64)

0 (0, 223.72)

+

1.39 (0.74, 2.62)

0.965 (0.343, 2.72)

1.9 (0.0756, 47.9)

Unadjusted
Adjustment 1

a,+

1.72 (0.856, 3.46)

1.09 (0.375, 3.15)

2.27 (0.111, 46.5)

Adjustment 2

b,+

1.98 (0.908, 4.3)

0.876 (0.268, 2.87)

1.45 (0.0714, 29.4)

Adjustment 3

c,+

1.76 (0.805, 3.85)

0.733 (0.219, 2.45)

1.66 (0.107, 25.7)

Figure 1. COVID-19 Outcomes Stratified by Race/Ethnicity in Each Quarter of Year 2020.
Abbreviations: COVID-19, coronavirus disease 2019; ICU, intensive care unit; OR, odds ratio; Q1, March
10, 2020, to March 31, 2020; Q2, April 1, 2020, to June 30, 2020; Q3, July 1, 2020, to Sep 2, 2020.
+
Logistic regression with Firth‚Äôs correction.
a
Multivariable logistic regression with adjustment 1 (age + sex + race/ethnicity). Population density was
also adjusted in the susceptibility (i.e. having positive test results) models.
b
Multivariable logistic regression with adjustment 2 (adjustment 1 + Neighborhood Socioeconomics
Disadvantage Index).
c
Multivariable logistic regression with adjustment 3 (adjustment 2 + comorbidity score).

23

medRxiv preprint doi: https://doi.org/10.1101/2021.01.02.21249140; this version posted January 4, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

A
Predictor

OR (95% CI)
OR

Black
95% CI
(L, U)

P
White

P
Black

P
int.

1.41 1.28 1.54

1.46 1.28 1.67

5.4e‚àí13 2.6e‚àí08 1

1.31 0.52 3.29

2.09 0.53 8.23

0.57

0.29

0.46

[35,50) yrs

1.21 0.68 2.15

2.36 1.17 4.77

0.52

0.017

0.20

2.03 1.22 3.39

3.71 1.84 7.50

0.0068

0.00026 0.30

[65,80) yrs

3.72 2.18 6.34

5.64 2.62 12.1

1.5e‚àí06 9.6e‚àí06 0.60

[80,100) yrs

11.5 5.54 23.8

16.5 4.61 59.0

5.3e‚àí11 1.6e‚àí05 0.81

1.67 1.23 2.27

2.18 1.44 3.30

0.0011

0.00022 0.33

BMI

1.02 1.00 1.04

1.02 0.99 1.05

0.052

0.21

0.60

BMI <18.5

3.59 0.80 16.2

6.50 0.85 49.7

0.096

0.071

0.67

1.56 0.99 2.48

1.51 0.60 3.79

0.058

0.38

0.99

1.69 1.09 2.63

1.78 0.76 4.17

0.020

0.19

0.98

1.12 0.80 1.56

0.96 0.61 1.51

0.51

0.87

0.52

1.13 0.80 1.59

1.12 0.69 1.82

0.48

0.64

0.83

1.07 0.50 2.33

0.47 0.17 1.33

0.86

0.15

0.21

0.85 0.58 1.24

0.72 0.45 1.14

0.41

0.16

0.71

Persons / square mile

1.06 0.99 1.14

1.09 0.99 1.20

0.10

0.087

0.67

NDI

5.04 0.51 50.1

7.10 1.03 48.9

0.17

0.046

0.85

Comorbidity score

1.29 1.16 1.44

1.12 0.98 1.29

4.3e‚àí06 0.098

0.15

Respiratory disease

0.93 0.63 1.36

1.15 0.70 1.90

0.71

0.54

Circulatory disease

1.83 1.21 2.77

1.15 0.65 2.04

0.0043

0.63

0.24

Any cancer

1.28 0.91 1.80

1.06 0.65 1.72

0.15

0.83

0.55

Type 2 diabetes

2.02 1.41 2.90

1.45 0.93 2.26

0.00012 0.098

Kidney disease

3.17 2.15 4.67

3.01 1.86 4.86

5.9e‚àí09 7e‚àí06

0.95

Liver disease

1.60 1.01 2.55

0.49 0.23 1.06

0.046

0.072

0.013

White
1.27 0.88 1.83
Black

0.92 0.57 1.48

0.21

0.72

0.24

[18,35) yrs

Female

Male

BMI [25,30)

Ever smoked
Past smoker
Current smoker
Alcohol drinker
SES

OR

[0,18) yrs

BMI [18.5,25)

BMI >=30

Comorbidities

White
95% CI
(L, U)

Age (unit: 10‚àíyear)

[50,65) yrs

Demographics

Reference
Category

Never
Never
Never

Autoimmune disease

0.5

1

2

5

20

0.59

0.33

50

B
Predictor

OR (95% CI)
OR

Black
95% CI
(L, U)

P
White

P
Black

P
int.

1.28 1.14 1.45

1.39 1.18 1.64

4.4e‚àí05 8.3e‚àí05 0.78

1.85 0.59 5.75

4.21 0.79 22.3

0.29

0.091

0.35

[35,50) yrs

1.06 0.47 2.36

1.70 0.60 4.82

0.90

0.32

0.62

1.54 0.76 3.13

3.97 1.48 10.6

0.23

0.0060

0.23

[65,80) yrs

3.23 1.59 6.55

4.19 1.48 11.8

0.0012

0.0068

0.98

[80,100) yrs

4.36 1.79 10.6

7.79 2.03 29.9

0.0012

0.0028

0.72

2.13 1.43 3.18

2.57 1.55 4.27

0.00021 0.00025 0.56

BMI

0.99 0.96 1.02

1.02 0.99 1.06

0.48

0.21

BMI <18.5

7.18 1.64 31.6

0.46 0.01 17.1

0.0090

0.68

n/a

1.24 0.71 2.17

1.12 0.37 3.43

0.45

0.84

0.89

0.84 0.48 1.47

1.22 0.43 3.47

0.54

0.71

n/a

1.28 0.84 1.96

1.05 0.60 1.83

0.25

0.87

0.55

1.30 0.84 2.01

1.19 0.66 2.14

0.24

0.56

0.76

1.28 0.48 3.42

0.52 0.12 2.16

0.62

0.36

0.29

0.72 0.45 1.15

0.93 0.51 1.70

0.17

0.82

0.41

Persons / square mile

1.11 1.02 1.21

1.08 0.96 1.21

0.021

0.18

0.93

NDI

4.05 0.23 71.3

12.6 1.23 128

0.34

0.033

0.61

Comorbidity score

1.45 1.27 1.67

1.19 1.01 1.41

1.2e‚àí07 0.034

0.13

Respiratory disease

1.64 0.94 2.86

0.98 0.54 1.80

0.080

0.96

0.21

Circulatory disease

2.12 1.19 3.77

1.23 0.57 2.65

0.011

0.60

0.33

Any cancer

1.71 1.13 2.60

0.91 0.51 1.63

0.012

0.74

0.12

Type 2 diabetes

1.99 1.29 3.08

2.05 1.22 3.45

0.0019

0.0070

0.80

Kidney disease

3.53 2.26 5.53

3.62 2.10 6.25

3.4e‚àí08 3.8e‚àí06 0.88

1.75 1.01 3.05
White
1.50 0.95 2.36
Black

0.46 0.17 1.26

0.047

0.13

0.030

1.24 0.71 2.19

0.080

0.45

0.58

Male

BMI [25,30)

Ever smoked
Past smoker
Current smoker
Alcohol drinker
SES

OR

[0,18) yrs

[18,35) yrs

Female

BMI [18.5,25)

BMI >=30

Comorbidities

White
95% CI
(L, U)

Age (unit: 10‚àíyear)

[50,65) yrs

Demographics

Reference
Category

Never
Never
Never

Liver disease
Autoimmune disease

0.1

0.5

1

2

5

20

0.32

50

Figure 2. Hospitalization (A) and ICU Admission (B) for Black and White Patients in the Full Cohort.
Abbreviations: BMI, body mass index; NDI, Neighborhood Socioeconomic Disadvantage Index.
The results were from model  ‡Æº‡Øà‡Øè‡ØÇ‡ÆΩ 1| , !"#$#% &‡¨¥  &‡Øë  &‡Øã‡Øî‡Øñ‡Øò '#(%  &‡Øú‡Ø°‡Øß ) '#(% 
&‡Æº‡Ø¢‡Ø© !"#$#%, where ‡Æº‡Øà‡Øè‡ØÇ‡ÆΩ denotes hospitalization (A) or ICU admission (B), and !"#$#%=age + sex
+ NDI (+ comorbidity score in the demographic and socioeconomic status models). Results that are
statistically significant at the level of 0.05 are bolded.

24

